uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Regulation of Angiogenesis
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Genetics and Pathology.
2001 (English)Doctoral thesis, comprehensive summary (Other academic)
Abstract [en]

Angiogenesis is the formation of new blood vessels from pre-existing ones. New blood vessel formation is fundamental in processes such as reproduction, embryonic development and wound healing. Growth of neoplasms is accompanied by increased angiogenesis. This thesis describes cellular and molecular mechanisms of importance for angiogenesis. The effects of a number of different anti-angiogenic substances on tumor growth were investigated.

Fibroblast growth factor-2 (FGF-2) is involved in different processes in angiogenesis. We have shown that Crk, an adaptor protein, participates in signaling downstream of FGF receptor-1, via the juxtamembrane tyrosine residue 463. Signal transduction through FGF receptor-1 and Crk regulates endothelial cell proliferation.

Anti-angiogenic effects of endostatin, latent antithrombin and prelatent antithrombin were evaluated. We found that FGF-2- and vascular endothelial growth factor (VEGF)- induced angiogenesis in the chick chorioallantoic membrane assay is inhibited by these anti-angiogenic substances, which also efficiently reduce tumor growth in mice.

Molecular mechanisms underlying the anti-angiogenic effects were investigated and endostatin was found to mediate its activity through induction of a 125 kDa kinase, leading to apoptosis. Endostatin was shown to be dependent on heparin/heparan sulfate binding for angiogenesis inhibition only in FGF-2- stimulated vessels, and not in those stimulated with VEGF. A peptide encompassing residues 180-199 in endostatin, capable of mimicking the effects of endostatin on endothelial cells was identified. Latent antithrombin and prelatent antithrornbin were found to exert their anti-angiogenic effects through negative regulation of focal adhesion kinase and focal adhesion formation.

Place, publisher, year, edition, pages
Uppsala: Acta Universitatis Upsaliensis , 2001. , 53 p.
Series
Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, ISSN 0282-7476 ; 1004
Keyword [en]
Genetics, angiogenesis, anti-angiogenesis, endostatin, latent antithrombin, prelatent antithrombin, Crk
Keyword [sv]
Genetik
National Category
Medical Genetics
Research subject
Pathology
Identifiers
URN: urn:nbn:se:uu:diva-606ISBN: 91-554-4954-9 (print)OAI: oai:DiVA.org:uu-606DiVA: diva2:167252
Public defence
2001-03-30, Rudbecksalen, Rudbecklaboratoriet, Box 510, 751 20 Uppsala, Uppsala, 09:15 (English)
Available from: 2001-03-09 Created: 2001-03-09 Last updated: 2009-08-26Bibliographically approved

Open Access in DiVA

No full text
Buy this publication >>

By organisation
Department of Genetics and Pathology
Medical Genetics

Search outside of DiVA

GoogleGoogle Scholar

isbn
urn-nbn

Altmetric score

isbn
urn-nbn
Total: 710 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf